Elizabeth (Beth) White is a highly experienced biopharmaceutical senior executive with a unique ability to bridge business strategy and scientific innovation who has made a smooth transition from large pharma to entrepreneurial biotech. Beth has built a very broad skill set gained through leadership roles over a
35-year career spanning drug development, portfolio prioritization, strategic planning, new company formation, business development, operations, fundraising, corporate communications, commercial planning, and global brand management. With a specialized understanding of genetic medicines and gene therapy, she is experienced in many therapeutic areas with strong expertise in rare diseases.
Dr. White is dedicated to helping emerging biotechnology companies successfully and efficiently translate their innovative technologies into accessible medicines that will help patients in need. She holds MS and PhD degrees with a concentration in molecular and cellular biology from the University of Rochester and a BS in Biology from Allegheny College.